Day One Biopharmaceuticals's total assets for Q4 2025 were $507.83M, a decrease of -1.16% from the previous quarter. DAWN total liabilities were $66.67M for the fiscal quarter, a 5.97% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.